Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker

Brain Research

Volumn 951, Issue 2, 2002, Pages 336-340

  Todorovic, Slobodan M ^a   Meyenburg, Adam ^b   Jevtovic Todorovic, Vesna ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mechanical nociception; Peripheral sensory neuron; Thermal nociception

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; MIBEFRADIL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MECHANICAL STIMULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION;

ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEAT; INJECTIONS, INTRAPERITONEAL; MIBEFRADIL; PAIN MEASUREMENT; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037019860     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03350-4     Document Type: Article

References (20)

1. 2+ channel antagonist mibefradil (Ro 40-5967). Mol. Pharmacol. 48:1995;540-549.
2. 2+ channel in vertebrate sensory neurons. Nature. 310:1984;501-502.
3. Clozel J.-P., Ertel E.A., I Ertel S. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J. Hypertension Suppl. 15:1997;S17-S25.
4. Dogrul A., Yesilyurt O., Isimer A., Guzeldemir M.E. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective μ opioid agonist, but not to selective δ and κ agonist at the level of the spinal cord in mice. Pain. 93:2001;61-68.
5. 2+ channel blocker. Exp. Opin. Invest. Drugs. 6:1997;569-582.
6. 2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc. Drugs Ther. 11:1997;723-739.
7. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
8. Huguenard J.R. Low-threshold calcium currents in central nervous system neurons. Annu. Rev. Physiol. 58:1996;329-358.
9. Jevtovic-Todorovic V., Wozniak D.F., Powell S., Nardi A., Olney J.W. Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects. Brain Res. 781:1988;202-211.
10. Karam H., Clozel J.-P., Bruneval P., Gonzalez M.-F., Menard J. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Hypertension. 34:1999;673-678.
11. McDonough S.I., Bean B.P. Mibefradil inhibition of T-type calcium channels in cerebellar Purkinje neurons. Mol. Pharm. 54:1998;1080-1087.
12. Miller R.J. Presynaptic receptors. Annu. Rev. Pharmacol.Toxicol. 38:1998;201-227.
13. Paquette F., Jasmin G., Dumont L. Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters. Cardiovasc. Drugs Ther. 13:1999;525-530.
14. Randal A.D., Tsien R.W. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels. Neuropharmacology. 36:1997;879-893.
15. Sandmann S., Bohle R.M., Dreyer T., Unger T. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats. Virchows Arch. 436:2000;147-157.
16. Scroggs R.S., Fox A.P. Calcium current variation between acutely isolated rat dorsal root ganglion neurons of different size. J. Physiol. (Lond.). 445:1992;639-658.
17. Todorovic S.M., Jevtovic-Todorovic V., Meyenburg A., Mennerick S., Perez-Reyes E., Romano C., Olney J.W., Zorumski C.F. Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron. 31:2001;75-85.
18. 2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J. Neurophysiol. 79:1998;240-252.
19. White D.M., Cousins M.J. Effect of subcutaneous administration of calcium channel lockers on nerve injury-induced hyperalgesia. Brain Res. 801:1998;50-58.
20. Wozniak D.F., Olney J.W., Kettinger III L., Price M., Miller J.P. Behavioral effects of MK-801 in the rat. Psychopharmacology. 101:1990;47-56.